Medication incidents involving smoking cessation therapies
Canadian Pharmacists Conference ePoster Library. Ho C. Jun 25, 2016; 132149
Dr. Certina Ho
Dr. Certina Ho
Login now to access Regular content available to all registered users.

You may also access this content "anytime, anywhere" with the Free MULTILEARNING App for iOS and Android
Abstract
Rate & Comment (0)
OBJECTIVES: Ontario pharmacists have been granted the authority to prescribe medications for smoking cessation in their expanded scope of practice. To help pharmacists minimize errors when prescribing for smoking cessation, medication incidents involving Varenicline and Bupropion must be examined. The objective of this project was to identify areas of vulnerabilities when prescribing and dispensing of smoking cessation therapies.,METHODS: A qualitative, multi-incident analysis was conducted using anonymous incident reports submitted to the Institute for Safe Medication Practices Canada Community Pharmacy Incident Reporting Program. Medication incidents involving Varenicline and Bupropion were included in the analysis.,RESULTS: A total of 360 incidents were analyzed. Our findings were divided into two main themes according to the medication therapies: (1) Varenicline and (2) Bupropion. The main themes were then further divided into subthemes, comprising of prescription instructions, quantity of tablets, and drug formulation. Safety interventions include separation of instructions for starter pack and continuation packs, implementation of preprinted order forms and independent double checks in the pharmacy workflow, and verification of the medication with patients during patient counselling.,CONCLUSIONS: As more patients access smoking cessation therapies, there are more opportunities for pharmacist-patient interactions. With pharmacists' expanded scope of practice, there is also a new potential for near misses and incidents involving prescribing errors in the pharmacy. Through shared learning of existing smoking cessation medication incidents from this project, pharmacists will be more prepared and aware of safe medication use when executing their expanded scopes.
    This eLearning portal is powered by:
    This eLearning portal is powered by MULTIEPORTAL
Anonymous User Privacy Preferences

Strictly Necessary Cookies (Always Active)

MULTILEARNING platforms and tools hereinafter referred as “MLG SOFTWARE” are provided to you as pure educational platforms/services requiring cookies to operate. In the case of the MLG SOFTWARE, cookies are essential for the Platform to function properly for the provision of education. If these cookies are disabled, a large subset of the functionality provided by the Platform will either be unavailable or cease to work as expected. The MLG SOFTWARE do not capture non-essential activities such as menu items and listings you click on or pages viewed.


Performance Cookies

Performance cookies are used to analyse how visitors use a website in order to provide a better user experience.


Save Settings